144 related articles for article (PubMed ID: 18486052)
1. PA-824.
Tuberculosis (Edinb); 2008 Mar; 88(2):134-6. PubMed ID: 18486052
[No Abstract] [Full Text] [Related]
2. OPC-67683.
Tuberculosis (Edinb); 2008 Mar; 88(2):132-3. PubMed ID: 18486051
[No Abstract] [Full Text] [Related]
3. The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.
Denny WA; Palmer BD
Future Med Chem; 2010 Aug; 2(8):1295-304. PubMed ID: 21426020
[TBL] [Abstract][Full Text] [Related]
4. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824.
Bollo S; Núñez-Vergara LJ; Kang S; Zhang L; Boshoff HI; Barry CE; Squella JA; Dowd CS
Bioorg Med Chem Lett; 2011 Jan; 21(2):812-7. PubMed ID: 21168331
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824).
Kmentova I; Sutherland HS; Palmer BD; Blaser A; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM
J Med Chem; 2010 Dec; 53(23):8421-39. PubMed ID: 21069962
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of pretomanid (PA-824) oxazolidinone hybrids.
Rakesh ; Bruhn DF; Scherman MS; Singh AP; Yang L; Liu J; Lenaerts AJ; Lee RE
Bioorg Med Chem Lett; 2016 Jan; 26(2):388-391. PubMed ID: 26711150
[TBL] [Abstract][Full Text] [Related]
7. Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases.
Showalter HD
Molecules; 2020 Sep; 25(18):. PubMed ID: 32927749
[TBL] [Abstract][Full Text] [Related]
8. Microbiology. An antibiotic mimics immunity.
Nathan C
Science; 2008 Nov; 322(5906):1337-8. PubMed ID: 19039126
[No Abstract] [Full Text] [Related]
9. Molecule Property Analyses of Active Compounds for
Makarov V; Salina E; Reynolds RC; Kyaw Zin PP; Ekins S
J Med Chem; 2020 Sep; 63(17):8917-8955. PubMed ID: 32259446
[TBL] [Abstract][Full Text] [Related]
10. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.
Stover CK; Warrener P; VanDevanter DR; Sherman DR; Arain TM; Langhorne MH; Anderson SW; Towell JA; Yuan Y; McMurray DN; Kreiswirth BN; Barry CE; Baker WR
Nature; 2000 Jun; 405(6789):962-6. PubMed ID: 10879539
[TBL] [Abstract][Full Text] [Related]
11. Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall.
Squeglia F; Romano M; Ruggiero A; Berisio R
Curr Med Chem; 2017 Nov; 24(36):3954-3969. PubMed ID: 28183257
[TBL] [Abstract][Full Text] [Related]
12. Nitroimidazoles for the treatment of TB: past, present and future.
Mukherjee T; Boshoff H
Future Med Chem; 2011 Sep; 3(11):1427-54. PubMed ID: 21879846
[TBL] [Abstract][Full Text] [Related]
13. TMC-207.
Tuberculosis (Edinb); 2008 Mar; 88(2):168-9. PubMed ID: 18486063
[No Abstract] [Full Text] [Related]
14. Thioridazine.
Tuberculosis (Edinb); 2008 Mar; 88(2):164-7. PubMed ID: 18486062
[No Abstract] [Full Text] [Related]
15. Streptomycin.
Tuberculosis (Edinb); 2008 Mar; 88(2):162-3. PubMed ID: 18486061
[No Abstract] [Full Text] [Related]
16. Pyrazinamide.
Tuberculosis (Edinb); 2008 Mar; 88(2):141-4. PubMed ID: 18486055
[No Abstract] [Full Text] [Related]
17. Prothionamide.
Tuberculosis (Edinb); 2008 Mar; 88(2):139-40. PubMed ID: 18486054
[No Abstract] [Full Text] [Related]
18. Levofloxacin.
Tuberculosis (Edinb); 2008 Mar; 88(2):119-21. PubMed ID: 18486047
[No Abstract] [Full Text] [Related]
19. Kanamycin.
Tuberculosis (Edinb); 2008 Mar; 88(2):117-8. PubMed ID: 18486046
[No Abstract] [Full Text] [Related]
20. Isoniazid.
Tuberculosis (Edinb); 2008 Mar; 88(2):112-6. PubMed ID: 18486045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
